Many aspects of the immune system and mechanisms of immunomodulatory therapies remain to be elucidated in order to exploit fully the emerging opportunities. Those involved in the research and clinical applications of immunotherapy are challenged by the huge and intricate volumes of knowledge arising from this fast-evolving field. The journal Immunotherapy offers the scientific community an interdisciplinary forum, providing them with information on the most recent advances of various aspects of immunotherapies, in a concise format to aid navigation of this complex field.

Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.

为了充分利用新兴机会，免疫系统的许多方面和免疫调节疗法的机制仍有待阐明。参与免疫疗法研究和临床应用的人员面临着来自这个快速发展的领域的大量复杂知识的挑战。《免疫疗法》杂志为科学界提供了一个跨学科论坛，以简明扼要的格式为他们提供有关免疫疗法各个方面最新进展的信息，以帮助他们驾驭这个复杂的领域。

《免疫疗法》以简明扼要、一目了然的文章格式提供重要信息。国际专家报告和分析了该领域的关键进展，为这个至关重要的研究领域提供了一个权威但易于理解的论坛。欢迎主动提交文章提案，作者必须完全遵守该期刊的披露和利益冲突政策以及主要出版指南，包括 ICMJE 和 GPP3。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-免疫学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为2.7，平均审稿速度为 较慢,6-12周 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。